PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50122C00007 — PROCURE A PANDEMIC INFLUENZA VACCINE (PANDFLU) AND A QUADRIVALENT SEASONAL INFLUENZA VACCINE (QSFLU)

PROCURE A PANDEMIC INFLUENZA VACCINE (PANDFLU) AND A QUADRIVALENT SEASONAL INFLUENZA VACCINE (QSFLU) is a federal NONE award for Department of Health and Human Services (HHS) held by ARCTURUS THERAPEUTICS INC. Estimated value $63.2M ($63.2M obligated). Current period of performance ends Aug 20, 2026. Last award drew 1 bidder.

$63.2M
Estimated Value
Aug 20, 2026
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

ARCTURUS THERAPEUTICS INC holds — across 1 federal awards. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Aug 20, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75A50122C00007
AgencyDepartment of Health and Human Services (HHS)
IncumbentARCTURUS THERAPEUTICS INC
UEIE3MFDBN4L3J9
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN14
PoP end (current)Aug 20, 2026
Obligated$63.2M

PROCURE A PANDEMIC INFLUENZA VACCINE (PANDFLU) AND A QUADRIVALENT SEASONAL INFLUENZA VACCINE (QSFLU)

Recompete timing

Public
Expiring in 3 days

Current PoP ends Aug 20, 2026 (3 days remaining). Agencies typically plan 12–18 months ahead — at 0.1 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

ARCTURUS THERAPEUTICS INC obligated across 1 awards (firm-wide, all agencies).

Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75A50122C00007
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open ARCTURUS THERAPEUTICS INC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50122C00007?

75A50122C00007 (PROCURE A PANDEMIC INFLUENZA VACCINE (PANDFLU) AND A QUADRIVALENT SEASONAL INFLUENZA VACCINE (QSFLU)) is a Department of Health and Human Services (HHS) award with an estimated value of $63.2M, currently held by ARCTURUS THERAPEUTICS INC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50122C00007?

ARCTURUS THERAPEUTICS INC is the incumbent with — across 1 related awards in SCOUT’s public footprint. The current period of performance ends Aug 20, 2026.

When does 75A50122C00007 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 20, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50122C00007